Javier Rodriguez
General Counsel at BIOXCEL THERAPEUTICS, INC.
Net worth: 15 193 $ as of 2024-05-30
Network origin in Javier Rodriguez first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Major | 22 |
| Public Company | Biotechnology | 18 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Javier Rodriguez via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Data Processing Services | Director/Board Member Chief Executive Officer Founder Corporate Officer/Principal | |
| Virginia Commonwealth University | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
| ADIAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| QUINCE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member Chairman | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director of Finance/CFO Public Communications Contact | |
Reckitt Benckiser Health Ltd.
 Reckitt Benckiser Health Ltd. Medical DistributorsDistribution Services Part of Reckitt Benckiser Group Plc, Reckitt Benckiser Health Ltd. is a British company that sells health care products and engages in research, development, and management activities. The company is based in Slough, UK. Founded in 2017. | Medical Distributors | Director/Board Member Director/Board Member | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Director/Board Member | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Sheffield | College/University | Undergraduate Degree | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
| Baines Peter Consulting | Director/Board Member | ||
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| Apterna Ltd. | Director/Board Member | ||
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014. | Financial Conglomerates | Director/Board Member | |
| BIOCON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chairman | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Public Communications Contact | |
| KINGFISHER PLC | Home Improvement Chains | Corporate Secretary | |
| BURBERRY GROUP PLC | Apparel/Footwear | Corporate Officer/Principal | |
Indivior UK Finance Ltd.
 Indivior UK Finance Ltd. Finance/Rental/LeasingFinance Part of Indivior PLC, Indivior UK Finance Ltd. provides financing services. The company is based in Slough, UK. Founded in 2019. | Finance/Rental/Leasing | Director/Board Member | |
Indivior UK Finance Lending Ltd.
 Indivior UK Finance Lending Ltd. Finance/Rental/LeasingFinance Part of Indivior PLC, Indivior UK Finance Lending Ltd. operates as a financing company. The company is based in Slough, UK. | Finance/Rental/Leasing | Director/Board Member | |
| ICAP PLC | Investment Banks/Brokers | Corporate Officer/Principal | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| University of Glasgow | College/University | Doctorate Degree | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| AXIS CAPITAL HOLDINGS LIMITED | Multi-Line Insurance | Director/Board Member |
Statistics
International
| United Kingdom | 24 |
| United States | 18 |
| India | 5 |
| Germany | 2 |
| Ireland | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 7 |
| Finance | 7 |
| Commercial Services | 5 |
| Consumer Non-Durables | 3 |
Operational
| Director/Board Member | 156 |
| Corporate Officer/Principal | 91 |
| Independent Dir/Board Member | 54 |
| Chief Tech/Sci/R&D Officer | 29 |
| Undergraduate Degree | 25 |
Most connected contacts
| Insiders | |
|---|---|
| Adrian Hennah | 29 |
| Howard H. Pien | 27 |
| Lizabeth Zlatkus | 24 |
| Cary Claiborne | 19 |
| Peter Bains | 19 |
| Christian Schade | 18 |
| Yvonne Greenstreet | 15 |
| Peter Mueller | 15 |
| Rupert Bondy | 14 |
| Michael Miller | 14 |
| Sandeep Laumas | 14 |
| Richard Steinhart | 12 |
| Rajiv Patni | 12 |
| Krishnan Nandabalan | 10 |
| Rosh Dias | 10 |
- Stock Market
- Insiders
- Javier Rodriguez
- Company connections
